Splinter Hemorrhage.
Grugan BM, Dyer SP.
J Emerg Med. 2022 Aug;63(2):304-305. doi: 10.1016/j.jemermed.2022.05.021. Epub 2022 Aug 29.
Nail Psoriasis.
Canal-García E, Bosch-Amate X, Belinchón I, Puig L.
Actas Dermosifiliogr. 2022 May;113(5):481-490. doi: 10.1016/j.ad.2022.01.006. Epub 2022 Feb 2.
Bevacizumab-induced subungual hemorrhage.
Owen JJ, Long S, Mullinax K, Griffin J.
Dermatol Online J. 2024 Oct 15;30(5). doi: 10.5070/D330564427.
Challenge of Nail Psoriasis: An Update Review.
Ji C, Wang H, Bao C, Zhang L, Ruan S, Zhang J, Gong T, Cheng B.
Clin Rev Allergy Immunol. 2021 Dec;61(3):377-402. doi: 10.1007/s12016-021-08896-9. Epub 2021 Sep 3.
Raynaud's phenomenon and splinter hemorrhage: an early telltale sign of cannabis arteritis.
Palaniappan V, Sadhasivamohan A, Karthikeyan K.
Int J Dermatol. 2022 Dec;61(12):e480-e483. doi: 10.1111/ijd.16143. Epub 2022 Mar 3.
Clinical Image: Splinter hemorrhage as a diagnostic clue of muscular polyarteritis nodosa.
Yoshida M, Taniguchi Y.
ACR Open Rheumatol. 2021 Oct;3(10):707. doi: 10.1002/acr2.11313. Epub 2021 Jul 29.
Splinter hemorrhage.
GILSTON RJ.
GP. 1955 Jan;11(1):103.
Nail pitting and splinter hemorrhage possibly induced by zolpidem.
Komori T, Otsuka A, Cho M, Honda T, Kabashima K.
J Dermatol. 2019 May;46(5):e151-e152. doi: 10.1111/1346-8138.14715. Epub 2018 Dec 3.
Splinter hemorrhages of the nails: a systematic review of clinical features and associated conditions.
Haber R, Khoury R, Kechichian E, Tomb R.
Int J Dermatol. 2016 Dec;55(12):1304-1310. doi: 10.1111/ijd.13347. Epub 2016 Jul 15.
Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects.
Hartmann JT, Haap M, Kopp HG, Lipp HP.
Curr Drug Metab. 2009 Jun;10(5):470-81. doi: 10.2174/138920009788897975.
